Boston Scientific’s AI leadership, global growth, and strong R&D make it a long-term winner despite valuation and regulatory ...

Abbott’s Q2 showed resilience amid macro risks, with its dividend strength and fair valuation reinforcing long-term appeal.

Lucid posted deeper Q2 losses and cut its 2025 outlook, but strong liquidity and a key Uber deal support long-term growth. Find out why LCID stock is a buy.

APA Corp. is generating strong cash flow, reducing debt. APA stock offers a 5.5% dividend yield, making it a compelling ...

Read thorough research and investment insights by Kenny Chan on Seeking Alpha here. View their credentials, investment style, areas of focus, and more.

Gold stocks surge as macro fundamentals improve. Discover why quality gold miners thrive in this bullish setup amid a ...

Visa upgraded to 'Buy' for strong financials, evolving B2B focus, exceptional profitability, and reliable growth, despite ...

Arbor Realty’s dividend cut and weak coverage keep me neutral on common shares, despite strong origination and NPL ...

Jussi Askola is the President of Leonberg Capital, a value-oriented investment boutique that consults hedge funds, family ...

Warner Bros. Discovery outpaces the S&P 500 with streaming growth, strong financials, and global appeal. Read here for an ...

Gulfport trimmed 2025 output guidance after midstream issues but shows solid well results and cuts dilution via $379M ...

Read about how to grow resilient passive income with a balanced dividend growth strategy, focusing on quality, stability, and ...